课题基金 / 基金详情

Multimerisation of ELAV/Hu proteins - a key mechanism ensuring specificity for RNA recognition in health and disease

Multimerisation of ELAV/Hu proteins - a key mechanism ensuring specificity for RNA recognition in health and disease
ELAV/Hu 蛋白的多聚化——确保健康和疾病中 RNA 识别特异性的关键机制
批准号:
2434274
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2020
资助国家:
英国
项目状态:
已结题
起止时间:
2020 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ELAV/Hu proteins comprise a family of highly conserved RNA binding proteins predominantly expressed in neurons where they have roles in regulating synaptic connectivity important for learning and memory. Aberrant regulation of ELAV/Hu proteins has been linked to neurodegenerative diseases such as Alzheimer's and Parkinson's disease. In addition, a number of cancers aberrantly express ELAV/Hu proteins including glioblastoma, pancreatic, colorectal and lung cancers, but the molecular mechanisms leading to these diseases are not understood.RNA binding proteins bind short motifs. These motifs, however, are degenerate and highly redundant in the genome. How they exactly generate specificity to filter the correct targets in such a degenerate sequence space, is currently not clear, but likely includes combinatorial interactions of RNA binding proteins. We have discovered that ELAV/Hu proteins can multimerize. Now we will employ cryoEM to build a structure for multimeric ELAV complexes bound to RNA and test the role of multimerization mediated RNA recognition in neurodegeneration and cancer using a Drosophila genetic model.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
ELAV蛋白在家蚕生长发育中的分子机制研究
水稻中ELAV/Hu类RNA结合蛋白的功能特征和作用机理研究
  • 批准号:
    31500979
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2015
  • 负责人:
    林学磊
  • 依托单位: